Controlled drug delivery in gut
Philips Research has recently announced its intelligent pill technology iPill, targeted at assisting drug development and enabling new therapies for digestive tract disorders such as Crohn’s disease, colitis and colon cancer.
The iPill is a capsule the same size as a camera pill that can be electronically programmed to control the delivery of medicine according to a predefined drug release profile.
The pill determines its location in the intestinal tract by measuring the local acidity of its environment, coupled with data about the capsule transit times. The pill releases medicine from its drug reservoir via a microprocessor-controlled pump, allowing accurate programmable drug delivery.
In addition, the capsule is designed to measure local temperature and report measurements wirelessly to an external receiver unit.
Proteomics International PromarkerD predictive test for diabetic kidney disease
The product is a clinically validated blood test that can predict the risk of developing chronic...
Phenosys Jet Ball rodent virtual reality system
The Jet Ball by Phenosys is a novel virtual reality experimental system based on an air...
Illumina Nextera Flex for Enrichment sequencing solution
The Illumina Nextera Flex for Enrichment is a targeted sequencing solution.
